| Year |
Citation |
Score |
| 2020 |
Ponzi A, Barton SJ, Bunner KD, Rangel-Barajas C, Zhang ES, Miller BR, Rebec GV, Kozloski J. Striatal network modeling in Huntington's Disease. Plos Computational Biology. 16: e1007648. PMID 32302302 DOI: 10.1371/journal.pcbi.1007648 |
0.611 |
|
| 2012 |
Miller BR, Dorner JL, Bunner KD, Gaither TW, Klein EL, Barton SJ, Rebec GV. Up-regulation of GLT1 reverses the deficit in cortically evoked striatal ascorbate efflux in the R6/2 mouse model of Huntington's disease. Journal of Neurochemistry. 121: 629-38. PMID 22332910 DOI: 10.1111/J.1471-4159.2012.07691.X |
0.773 |
|
| 2011 |
Miller BR, Walker AG, Barton SJ, Rebec GV. Dysregulated Neuronal Activity Patterns Implicate Corticostriatal Circuit Dysfunction in Multiple Rodent Models of Huntington's Disease. Frontiers in Systems Neuroscience. 5: 26. PMID 21629717 DOI: 10.3389/fnsys.2011.00026 |
0.794 |
|
| 2010 |
Miller BR, Bezprozvanny I. Corticostriatal circuit dysfunction in Huntington's disease: intersection of glutamate, dopamine and calcium. Future Neurology. 5: 735-756. PMID 21977007 DOI: 10.2217/Fnl.10.41 |
0.411 |
|
| 2010 |
Ball KT, Wellman CL, Miller BR, Rebec GV. Electrophysiological and structural alterations in striatum associated with behavioral sensitization to (±)3,4-methylenedioxymethamphetamine (Ecstasy) in rats: role of drug context. Neuroscience. 171: 794-811. PMID 20875842 DOI: 10.1016/J.Neuroscience.2010.09.041 |
0.694 |
|
| 2010 |
Sari Y, Prieto AL, Barton SJ, Miller BR, Rebec GV. Ceftriaxone-induced up-regulation of cortical and striatal GLT1 in the R6/2 model of Huntington's disease. Journal of Biomedical Science. 17: 62. PMID 20663216 DOI: 10.1186/1423-0127-17-62 |
0.685 |
|
| 2010 |
Miller BR, Walker AG, Fowler SC, von Hörsten S, Riess O, Johnson MA, Rebec GV. Dysregulation of coordinated neuronal firing patterns in striatum of freely behaving transgenic rats that model Huntington's disease. Neurobiology of Disease. 37: 106-13. PMID 19818852 DOI: 10.1016/J.Nbd.2009.09.013 |
0.762 |
|
| 2009 |
Dorner JL, Miller BR, Klein EL, Murphy-Nakhnikian A, Andrews RL, Barton SJ, Rebec GV. Corticostriatal dysfunction underlies diminished striatal ascorbate release in the R6/2 mouse model of Huntington's disease. Brain Research. 1290: 111-20. PMID 19616518 DOI: 10.1016/J.Brainres.2009.07.019 |
0.757 |
|
| 2009 |
Fowler SC, Miller BR, Gaither TW, Johnson MA, Rebec GV. Force-plate quantification of progressive behavioral deficits in the R6/2 mouse model of Huntington's disease. Behavioural Brain Research. 202: 130-7. PMID 19447289 DOI: 10.1016/J.Bbr.2009.03.022 |
0.674 |
|
| 2008 |
Walker AG, Miller BR, Fritsch JN, Barton SJ, Rebec GV. Altered information processing in the prefrontal cortex of Huntington's disease mouse models. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 8973-82. PMID 18768691 DOI: 10.1523/JNEUROSCI.2804-08.2008 |
0.788 |
|
| 2008 |
Miller BR, Walker AG, Shah AS, Barton SJ, Rebec GV. Dysregulated information processing by medium spiny neurons in striatum of freely behaving mouse models of Huntington's disease. Journal of Neurophysiology. 100: 2205-16. PMID 18667541 DOI: 10.1152/jn.90606.2008 |
0.788 |
|
| 2008 |
Miller BR, Dorner JL, Shou M, Sari Y, Barton SJ, Sengelaub DR, Kennedy RT, Rebec GV. Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6/2 mouse. Neuroscience. 153: 329-37. PMID 18353560 DOI: 10.1016/J.Neuroscience.2008.02.004 |
0.768 |
|
| 2007 |
Liu X, Miller BR, Rebec GV, Clemmer DE. Protein expression in the striatum and cortex regions of the brain for a mouse model of Huntington's disease. Journal of Proteome Research. 6: 3134-42. PMID 17625815 DOI: 10.1021/Pr070092S |
0.598 |
|
| 2007 |
Dorner JL, Miller BR, Barton SJ, Brock TJ, Rebec GV. Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington's disease. Behavioural Brain Research. 178: 90-7. PMID 17239451 DOI: 10.1016/J.Bbr.2006.12.004 |
0.77 |
|
| Show low-probability matches. |